Entellus Medical Seals $35M in Fresh VC
Entellus Medical Inc., a medical device company focused on treatments for chronic sinusitis, has inked $35 million in fresh capital. Covidien Ventures led the round, which included existing investors SV Life Sciences, Essex Woodlands, Split Rock Partners and Greenspring Associates. The money will help Entellus continue efforts to commercialize the company’s products.
18 August 2011•3 mins read
